Patent Oppositions in antibodies industry

Explore the competitive field of antibodies where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in antibodies technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the antibodies industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the antibodies industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jan 22, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Chimeric Antigen Receptors Targeting B-Cell Maturation AntigenTHE USA REPRESENTED BY THE SECRETARYDec 31, 2025BOULT WADE TENNANT
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 19, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To LeukocytesRAMOT AT TEL AVIV UNIVERSITYDec 18, 2025KARO
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 18, 2025ADVANZ PHARMA SERVICES UK
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 17, 2025BRAND MURRAY FULLER
Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To LeukocytesRAMOT AT TEL AVIV UNIVERSITYDec 15, 2025STRAWMAN
A Myostatin Pathway Inhibitor In Combination With A Glp-1 Pathway Activator For Use In Treating Metabolic DisordersSCHOLAR ROCKDec 3, 2025MARGARET DIXON
Anti-Pd-L1 Antibodies And Their Use To Enhance T-Cell FunctionROCHENov 28, 2025SANDOZ
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEOct 29, 2025ABEL & IMRAY
Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHEOct 28, 2025J A KEMP

To stay ahead in the competitive antibodies industry, companies are constantly innovating. Here are the top patents facing oppositions in the antibodies industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jan 22, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Jan 10, 2018Method To Improve Virus Removal In Protein PurificationGENENTECH11
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLUDWIG MAXIMILIANS UNIVERSITT MNCHEN10
May 15, 2019Combination Therapy For The Treatment Of Ovarian CancerF HOFFMANN LA ROCHE10
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITY10
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHE9
Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB9
Sep 11, 2019Binding Molecules For Bcma And Cd3AMGEN RESEARCH MUNICH8
Aug 21, 2019Binding Molecules For Bcma And Cd3AMGEN RESEARCH MUNICH7
May 10, 2017Protein Purification MethodCHUGAI SEIYAKU KABUSHIKI KAISHA7